Objective: To compare the attitudes and opinions of otologists and neurologists regarding the cause, diagnosis, and management of vestibular migraine. Study Design: Survey questionnaire. Methods: An 18-question survey designed to elicit opinions about the cause, diagnosis, pathophysiology, and management of migraine and dizziness was mailed to the entire memberships of the American Neurotology Society (ANS) and the International Headache Society (IHS). Survey participant responses were recorded for physician practice characteristics and for opinions on various clinical features of vestibular migraine. Results: Of the 917 surveys mailed, 146 were completed by ANS members and 110 by IHS members. The frequency of respondents listing symptom origin as central to a diagnosis of migraine was 43% for ANS members versus 62% of IHS members. Only 31% of ANS respondents thought that a sensory trigger was a major etiologic factor. Of the IHS respondents, 60% thought a triggering event was mediated by the Vth nerve and 28% by the VIIIth nerve. Opinions varied on the character of dizziness and cochlear symptoms associated with migraine. Compared with 26% of IHS members, 55% of ANS members were more likely to view hearing loss as a migraine symptom. IHS members expressed a greater tendency to use triptans and anticonvulsants when compared with ANS members.
The association between migraine and vestibular symptoms is becoming more widely accepted as crossdisciplinary communication improves among specialists who treat patients at risk for migraine. Although a link between dizziness and a migraine event was described by the ancient Greek physician, Aretaeus of Cappadocia, in 131 B.C. (1), vestibular migraine was mentioned infrequently in the medical literature until the mid-1990s. The one notable exception was an article on megrim published in 1873 in which the Victorian physician, Edward Living, noted a connection between migraine and vertigo in certain patients (2) .
A PubMed search of pertinent literature published since 1985 reveals that the number of articles addressing a relationship between dizziness and migraine has grown exponentially over the past 25 years. Search results retrieved for 5-year increments between 1990 and 2009 indicate that the number of published articles identified via the key words migraine and vertigo has almost dou- Similarly, the number of published evidence-based clinical descriptions of the pathophysiology of migraine headache has increased for the past 10 years. Based on recent trends in the pertinent literature, it seems that there is a growing consensus among clinicians who view migraine as a form of sensory processing disturbance. Migraine has multiple precipitating factors, such as diet, stress, sleep deprivation, bright light, or hormonal changes. These stimuli trigger a response as a result of an inherited reduced threshold of cortical depolarization and are known to activate a cortical spreading depression or short-lasting depolarization wave. The depression then activates peripheral neurons and meningeal vessels, which in turn activate central neurons, including the trigeminal nucleus caudalis and higher order neurons that lead to central sensitization (3) . Although new data have emerged on the cause and clinical sequelae of migraine headache, comparable information is not yet available for vestibular migraine. Despite the common occurrence of vestibular symptoms in conjunction with migraine, the current understanding of the pathophysiology, presenting symptoms, associated cochlear symptoms, and treatment of vestibular migraine still lags behind the research and understanding of migraine headache. Factors, such as the well-established association between migraine and susceptibility to motion sickness and the 3-fold increased incidence of benign positional vertigo in the migraine population, may add to the uncertainty surrounding the diagnostic criteria of vestibular migraine (4Y6).
As dizziness is one of the most common presenting complaints in this country, the need for physicians to evaluate vertigo and related conditions has sparked new interest in the relationship of migraine and dizziness, as well as in the pathogenesis of both disorders. Migraine affects 43% of women and 18% of men at some point in their lives (7) , and 30% to 50% of patients with migraine experience some form of dizziness or vertigo (8Y11). Based on these statistics alone, migraine arguably should be one of the more common differential diagnoses in the patient presenting with dizziness in the United States. As a practicing otologist for more than 30 years, I (the primary author) have never seen a topic that has evoked so little consensus and has created so much confusion for both the patient and the referring primary physician as the diagnosis of vestibular migraine.
To better understand current perceptions of vestibular migraine and its treatment in the medical community, a voluntary survey was conducted seeking the opinion of 2 specialty groups (otologists and neurologists) most commonly called upon to treat patients presenting with dizziness. Prospective survey participants consisted of members of the American Neurotology Society (ANS), whom we considered to represent an otologic perspective, and members of the International Headache Society (IHS) who were assumed to hold a neurologic perspective.
The purpose of the survey was to compare the attitudes and opinions of otologists and neurologists regarding the cause, diagnosis, and management of vestibular migraine. The survey offers unique and perhaps seminal comparative data on the clinical opinions about migraine and dizziness held by these 2 professional groups. It should be noted that, although the responses from IHS members are presented as a collective response, only 67% of IHS members who participated in our survey were neurologists. The remaining members of the IHS defined themselves as internists and/or headache specialists.
METHODS
The authors mailed a survey questionnaire containing 18 basic areas of inquiry, including several with subcategories, to the entire memberships of the ANS and IHS. The questionnaire was used to collect data from physician respondents on specialization, years in practice, and the percentage of patients in each clinician_s practice that present with a complaint of dizziness or headache, and more specifically with migraine headache. The questions were designed to elicit information on each respondent_s medical knowledge of migraine and vertigo with respect to his own patient population. In addition, the survey queried physicians on their understanding of the pathophysiology and presenting characteristics of this condition as well as associated cochlear symptoms and treatment. The ANS responses were assumed to represent an otologic perspective, whereas the IHS answers were presumed to reflect the disciplinary view of neurologists and other headache specialists. The analysis of the survey results from this study is based on a comparison of responses obtained from members of these 2 professional medical organizations who completed the questionnaire. This comparison is based on an implicit understanding that the membership of the ANS does not consist exclusively of otologists and that of the IHS is not composed only of neurologists.
Statistical Methods
A chi square test of independence was used to evaluate differences between the 2 groups for categorical variables such as views on diagnostic criteria for vestibular migraine and on clinical practice management strategies, including predominant types of medication prescribed. All major differences, which were evaluated, were found to be significant at > = 0.001.
Institutional Review
A proposal for the study was submitted to the Aurora Healthcare Institutional Review Board, St. Lukes Hospital. The chairman of the Aurora Healthcare Institutional Review Board reviewed the study and, based on the study design, concluded that no review board approval was required to conduct the survey.
RESULTS
Of a total of 431 survey questionnaires mailed to all ANS members, 43 were returned as nondeliverable because of change of address or retirement. Twenty-one of the 486 questionnaires mailed to the full IHS membership were returned by the postal service as nondeliverable. Of the remaining 388 questionnaires sent to ANS members, 146 (37.6%) were completed and returned. Of the 465 deliverable questionnaires mailed to IHS members, 110 were completed and returned for a response rate of 23.6%. Each question was then evaluated for differences in opinion between the 2 groups. Physician practice data for the respondents are summarized in Table 1 . Table 2 presents comparative data on differences in clinical opinion between ANS and IHS members, based on the frequency of affirmative responses to migraine-related survey questions. All data which were found to be significant are indicated by an asterisk in Table 2 .
In the first part of the survey (Questions 1Y6), participants were asked about the demographic characteristics of their practice ( Table 1 ). The majority of respondents who belonged to the ANS (92%) listed their primary specialty as otology, whereas the IHS members consisted mainly of neurologists (67%), internists, and headache specialists combined in the IHS accounted for approximately 27% of the survey participants. Physicians with 10 to 20 years of experience as a specialist comprised the highest percentage of survey participants, followed by those with 30 or more years of practice in one of the designated specialties.
As expected, the 2 groups differed in the proportions of patients who presented with headache or vertigo as their primary complaint, ANS physicians overall treated a limited number of patients whose primary presenting complaint was headache, with 94.5% of these clinicians indicating that less than 21% of their patients presented with headaches. In the IHS group, a far greater number of patients presented with a primary complaint of headache, and these data can be seen in Table 1 . The distribution of patients presenting with dizziness to both specialty groups showed an opposite variation, with ANS members seeing more patients presenting with dizziness. Nearly 60% of ANS respondents indicated between 21% and 60% of their patients presented with dizziness; this compared with only 13% of IHS members selecting this range of patients presenting with dizziness (Table 1) .
When asked about the percentage of patients presenting with a complaint of dizziness who received a diagnosis of vestibular migraine, the majority of both ANS and IHS respondents (68.4% versus 67.5%) had diagnosed vestibular migraine in less than 21% of their patients with an initial symptom of dizziness. Six percent of ANS members versus 12% of IHS members reported never having rendered a diagnosis of vestibular migraine in patients presenting with a primary or major symptom of dizziness.
In the next part of the survey (Questions 7Y18), participants were asked to agree or disagree with various statements regarding vestibular migraine, including the role of dizziness in the cause and clinical course of migraine, diagnostic indicators, and treatment approaches ( Table 1 ). The vast majority of the ANS members (91%) and IHS members (95%) agreed that migraine could cause vestibular symptoms. Approximately 5% of the respondents in both groups were Bnot sure[ of a vestibular link to migraine. When queried further about vestibular symptoms, 84% of the ANS group versus 81% of the IHS participants concurred with the statement that vestibular symptoms could occur without concomitant headache. This implies that the remaining respondents (16% of the ANS versus 19.2% of the IHS members) either did not think that migraine-induced vestibular symptoms can exist without concomitant headache or were uncertain of the correct answer.
The response to the inquiry about vestibular symptom pathophysiology revealed that members of both groups thought strongly that vestibular symptoms could have a migraine origin. Yet the consensus weakened when the subsequent questions shifted to the physiologic mechanisms that are most likely responsible for migraineinduced vestibular symptoms. A greater percentage of members in both groups (45% versus 62% in the ANS and IHS, respectively) thought that the pathophysiology of vestibular migraineYassociated dizziness was central in the origin of migraine, with only small numbers indicating a peripheral origin. The rate of respondents who were unsure of the origin was 27.8% versus 34.2% for those in the ANS and IHS, respectively.
Nearly three-fourths of IHS members thought that a sensory trigger is responsible for the initiation of vestibular migraine, with most respondents (60%) identifying the trigeminal nerve as the pathway for the trigger. Of ANS respondents who answered this question, 30.8% When presented with multiple choice answers regarding the type of dizziness associated with migraine, the survey respondents had the option to select more than one answer from choices that included chronic disequilibrium, acute vertiginous attacks, positional vertigo, or motion sickness. Both groups (88.3% of ANS members versus 92.4% of IHS members) perceived acute vertigo as the most common symptom in vestibular migraine. Among the ANS respondents, 45.9% versus 36.7% of the IHS group thought migraine-associated dizziness could represent chronic disequilibrium (Fig. 1) . The difference in the percentage of IHS (69.8%) versus ANS participants (23.3%) who associated motion sickness with migraine was significant.
When asked if patients with vestibular migraine can have certain associated cochlear symptoms, more than twice as many ANS participants (56.2%) as compared with IHS respondents (26.4%) thought that hearing loss could be an associated symptom of vestibular migraine (Fig. 2) , a significant variation. The percentage of participants who were unsure if hearing loss could be linked with vestibular migraine was nearly two and a half times greater in IHS participants (37%) than in ANS respondents (15%). Nearly 70% of the survey takers in both groups recognized tinnitus as an associated symptom. Approximately 50% of the respondents in both the ANS and IHS thought that associated cochlear symptoms would present unilaterally. Responses as to the likelihood of cochlear symptoms manifesting bilaterally was selected by 22% of ANS members versus 40% of IHS.
To further explore the 2 groups_ opinions in regard to migraine and dizziness, respondents were asked about the most likely diagnosis in a patient presenting with complaints of vertigo and headache but without other posterior fossaYrelated symptoms. In the ANS group, 64.5% thought that the presence of vertigo and headache concurrently was consistent with a diagnosis of vestibular migraine. In the IHS group, 82% noted that they would diagnose the coexistence of these 2 symptoms as a vestibular migraine. Only 9% of the IHS members and 14% of the ANS group thought that the combination of vertigo and headache by itself would represent a diagnosis of basilar migraine. The remaining respondents were unsure of an exact answer.
In response to the first question on treatment, 19% of ANS participants and 14.5% of those in the IHS reported that they had never treated a patient with vestibular migraine. Therefore, the answers to the remaining survey questions about treatment were based on responses of approximately 77% of the ANS group and 85% of the IHS group. The distribution of medications utilized for vestibular migraine prophylaxis is presented in Figure 3 . The major difference between the 2 groups is evidenced in the use of anticonvulsants. IHS respondents (70%) prescribed anticonvulsants more frequently than ANS participants (19.8%). Members of both groups administered antidepressants, beta-blockers, and calcium channel blockers at similar frequencies.
Some clinical evidence suggests that the use of triptans in patients with basilar migraine may increase the risk of stroke (12) , in which case utilization of this therapy might be contraindicated in the treatment of vestibular migraine. Yet only a small proportion of members in each group linked triptans with increased stroke risk (2.7 % versus 8.5% in the ANS and IHS, respectively). Whereas 78% of ANS members were not sure if triptans raised stroke risk, IHS members overall did not express uncertainty about such an association between triptans and increased risk for cerebrovascular accident in patients with vestibular migraine. The 2 groups differed in the use of triptans for the acute management of vestibular migraine with IHS members more inclined to their use than ANS members.
The final 2 questions pertained to the survey participants_ use and knowledge of international disease classification codes. Forty-eight percent of ANS members versus 33.6% of IHS participants had used an International Classification of DiseasesY9th Revision (ICD-9) code for a diagnosis of episodic vertigo in childhood as a potential migraine event. The difference in the frequency of ANS (11.6%) versus IHS participants (62.1%) who had never coded for an episodic vertigo of childhood presumed to be of migraine origin was significant. A large percentage of survey respondents in both groups (67.8% 
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versus 55.5% for the ANS and HIS, respectively) did not know if an ICD-9 code existed for the diagnosis of vestibular migraine.
DISCUSSION
The objective of this study was to compare 2 groups of medical specialists with different training backgrounds in regard to their academic understanding and overall beliefs about the clinical assessment and treatment of vestibular migraine. The survey results revealed that specialists, within the 2 groups studied, primarily otologists and neurologists, varied in their views on key factors associated with this disorder. The findings underscore the lack of a standard knowledge base and a common understanding of vestibular migraine, at least among the self-selected respondents from the 2 medical organizations who participated in the survey.
Notable was a lack of consensus among the participants over the origin of vestibular symptoms in migraine. A larger proportion of respondents selected a central rather than peripheral origin of migraine ( Table 2) . The difference in the percentages of participants in the 2 groups who thought that the dizziness associated with vestibular migraine is a central vestibular event was significant, with IHS members more inclined toward a central origin. The absence of common ground was demonstrated further by the relatively high frequencies of respondents (34% versus 28% for ANS and IHS members, respectively) who selected Bnot sure[ as a response about the origin of symptoms. In retrospect, however, the responses to this survey question may have provided more precise information on the survey participants_ clinical knowledge if they had been given the option of choosing both a central and peripheral origin for a single answer.
The variation in the frequency of IHS versus ANS respondents (60% versus 8.9%) who viewed a vestibular migraine trigger as trigeminal in origin was significant. This variance between the 2 groups may result from different emphases in their academic training and clinical practice. For example, neurologists and headache specialists would be expected to interpret the pathophysiology of vestibular migraine in relation to general migraine pathophysiology, which includes activation of the trigeminal system. Otologists are more likely to view the peripheral vestibular system or visual input as a source of vestibular complaints and do not commonly recognize a clinical correlation between trigeminal stimulus and common otologic vestibular disorders.
The survey participants exhibited a wide range of opinions on the coexistence of cochlear symptoms and migraine and on whether those symptoms are unilateral or possibly bilateral. The rates of respondents who recognized otic fullness and tinnitus as potential symptoms of vestibular migraine were comparable for members in the ANS and IHS. However, the difference in the percentage of respondents who considered hearing loss as an associated symptom of vestibular migraine was significant (56.2% versus 26.4% for ANS and IHS members, respectively). It is not clear if this particular difference can be attributed to variation in academic education, clinical training, predominant conditions treated, or a combination of these factors that influence specialists_ perceptions of the primary defining clinical features of vestibular migraine. The variation in acceptance of coexisting cochlear symptoms, specifically hearing loss, may explain the significant difference in ANS (82%) versus IHS (62%) acceptance as to whether vestibular migraine can mimic Ménière_s syndrome. Discrepancies in these clinical perspectives could cause confusion for patients, and perhaps even for referred physicians, over the diagnosis and treatment of this condition. If the physician who examines a patient with vertigo dismisses hearing loss, tinnitus, or otic pressure as potential components of vestibular migraine, then he may eliminate migraine as a possible diagnosis.
Although precise statistics are lacking, it seems that some patients with cochlear symptoms may be mistakenly rendered a Ménière_s diagnosis and, therefore, administered inappropriate treatment protocols that are not effective in migraine treatment (13) .
The survey responses also suggest that members in the 2 societies may have distinct differences in their therapeutic approach to treating patients who present with symptoms of vertigo and/or headache. Although a large proportion of the IHS respondents who are migraine specialists utilized anticonvulsants, the ANS respondents overall preferred to use antidepressants and beta-blockers and prescribed anticonvulsants at a much lower rate. The group difference in the use of anticonvulsants was significant. The trend observed among ANS respondents may mean that their therapeutic approach is guided largely by their training, specifically their familiarity with prescribing certain classes of medications. Neurologists gain greater clinical experience through administering anticonvulsants for conditions they treat within their area of specialty, including epilepsy, headache, neuromuscular disorders, and pain syndromes. However, otologists in traditional otology residencies and continuing education programs do not undergo the same emphasis of clinical training in these disorders.
The data on therapeutic approaches revealed that approximately 19% of the ANS respondents and nearly 15% of IHS members had not treated patients with vestibular migraine. The reasons for this are not clear but may be due partly to the lack of clarity regarding the diagnosis of vestibular migraine. Accurate diagnosis of this condition is mandatory for determining the optimal management approach for this condition. The ambiguity of relevant terminology, including basic definitions, in the literature poses an important, although often unrecognized, problem for clinicians who treat patients with migraine and dizziness. For example, some entries in textbooks and current clinical study reports do not clearly distinguish among clinical entities such as vestibular migraine, migraineassociated dizziness, migraine-associated vertigo, migrainerelated vestibulopathy, and migrainous vertigo. Added to the confusion over terminology in the literature is the fact that motion intolerance and benign positional vertigo often coexist in migraine patients. In addition, the potential correlations reported between patients with migraine and mal de embarkment syndrome and those with visual vestibular mismatch syndrome might make a precise diagnosis of vestibular migraine more difficult. These factors may all contribute to the underdiagnosis of vestibular migraine, as noted in a 2006 study by Neuhauser et al. (14) , which found that only 20% of patients presenting with symptoms consistent with vestibular migraine received the appropriate diagnosis when seeking attention for their vertigo. Developing a uniform terminology and consistent definition of terms applicable to the dizziness experienced by migraine patients would be an important step toward improving the clinical understanding of this disease complex, a goal, which has been called for by a number of authors since the early 2000s (15, 16) .
Although multiple ICD-9 codes are currently available under code 376, for migraine headache, no ICD-9 code exists for vestibular migraine, beyond that used for migraine vertigo in pediatric patients. The lack of an ICD-9 code for an adult experiencing migraine vertigo without concomitant headache poses 2 problems. First, if a migraine code is selected for a vertiginous patient and no headache is present, then the selected code cannot be substantiated by the medical record. Second, the absence of a definitive code for vestibular migraine can impede the retrieval of retrospective data, which is essential for ongoing research of this disorder.
CONCLUSION
This pilot study generated comparative data on the clinical views and practice patterns relating to vestibular migraine in survey participants who are members in primarily 2 specialty groups. The survey was limited by a small survey sample size, the voluntary self-selection of participants, the low percentage of respondents, and the fact that one-third of IHS members are internists and/or headache specialists rather than neurologists. Furthermore, a practice survey, such as this, has inherent limitations because of its reliance on self-reported data.
Despite the limitations of this study, several significant differences observed between the 2 groups of respondents warrant further investigation. The survey results overall show that respondents in the 2 specialty groups do not share an understanding of the core features of vestibular migraine. The data also suggest that the 2 specialties may differ in some of their treatment approaches. If specialists who evaluate and treat patients with a presenting complaint of dizziness cannot identify vestibular migraine as a potential cause of this condition, appropriate treatment cannot be prescribed. Perhaps the most troubling response is that a number of clinicians may not even recognize that this problem exists. To overcome the apparent lack of knowledge, otologists and neurologists must agree on the diagnostic features of vestibular migraine. This consensus should be based on basic medical science and evidencebased clinical studies, made possible through a standardization of nomenclature and appropriate clinical coding. When an accord has been reached, then both groups of specialists will be better informed about the most effective options currently available for the management of patients presenting with vestibular migraine symptoms.
